Polivka, J.; Windrichova, J.; Pesta, M.; Houfkova, K.; Rezackova, H.; Macanova, T.; Vycital, O.; Kucera, R.; Slouka, D.; Topolcan, O.
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases. Cancers 2020, 12, 2434.
https://doi.org/10.3390/cancers12092434
AMA Style
Polivka J, Windrichova J, Pesta M, Houfkova K, Rezackova H, Macanova T, Vycital O, Kucera R, Slouka D, Topolcan O.
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases. Cancers. 2020; 12(9):2434.
https://doi.org/10.3390/cancers12092434
Chicago/Turabian Style
Polivka, Jiri, Jindra Windrichova, Martin Pesta, Katerina Houfkova, Hana Rezackova, Tereza Macanova, Ondrej Vycital, Radek Kucera, David Slouka, and Ondrej Topolcan.
2020. "The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases" Cancers 12, no. 9: 2434.
https://doi.org/10.3390/cancers12092434
APA Style
Polivka, J., Windrichova, J., Pesta, M., Houfkova, K., Rezackova, H., Macanova, T., Vycital, O., Kucera, R., Slouka, D., & Topolcan, O.
(2020). The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases. Cancers, 12(9), 2434.
https://doi.org/10.3390/cancers12092434
